Status:
RECRUITING
Is Clonal Hematopoiesis of Indeterminate Potential Associated With Unprovoked Pulmonary Embolism?
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Pulmonary Embolism
Hematopoiesis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The clonal hematopoiesis of indetermined prognosis (CHIP) has been described as risk factor for juvenile atherosclerosis. Moreover, some of CHIP genes are responsible of myeloproliferative disorders. ...
Eligibility Criteria
Inclusion
- For cases : Previous proximal unprovoked pulmonary embolism, negative thrombophilia screening.
- For control : Previous proximal provoked pulmonary embolism, negative thrombophilia screening.
Exclusion
- Age superior to 65 years old,
- Active cancer
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
544 Patients enrolled
Trial Details
Trial ID
NCT04711746
Start Date
February 1 2021
End Date
January 1 2026
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480